Erotas Pharmaceuticals Private Limited Company Logo

Erotas Pharmaceuticals Private Limited - Company Profile

It is a pharma private limited company based in Hyderabad, Telangana, India, established in 2020.

2020 | Hyderabad, Telangana, India | Active
Last Updated:

About Erotas Pharmaceuticals Private Limited

Erotas Pharmaceuticals Private Limited, a active private limited company, was established on 13 March 2020 in Hyderabad, Telangana, India. Engaging in pharma contract r&d within the trade sector, it holds CIN: U24230TG2020PTC139783. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.

Its leadership includes Pavani Kathi (Director), Ramesh Gamini (Director). Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at H. No. 5-3-74, Kukatpally,, Hyderabad, Telangana, 500072.

Company Details

  • CIN/LLPIN

    U24230TG2020PTC139783

  • Registration Number

    139783

  • Incorporation Date

    13 March 2020

  • Authorized Capital

    ₹0.10 M

  • Paid-Up Capital

    ₹0.10 M

  • ROC Code

    Roc Hyderabad

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Indicators

  • Authorised Capital ₹ 0.10 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 5 Year, 8 Months
  • Last Filing with ROC 31 Mar 2024
  • Revenue Growth -26.34%
  • Profit Growth 66.41%
  • Ebitda 45.41%
  • Net Worth 53.02%
  • Total Assets 139.73%
Company report

Erotas Pharmaceuticals Private Limited

Company Report FY 2025-2026

Explore comprehensive insights into Erotas Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report Banner Element

Who are the key members and board of directors at Erotas Pharmaceuticals Private Limited?

Current Directors

NameDesignationAppointment DateStatus
Pavani KathiDirector13 Mar 2020Current
Ramesh GaminiDirector13 Mar 2020Current

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Erotas Pharmaceuticals.

Erotas Pharmaceuticals Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 26.34% decrease. The company also saw a substantial improvement in profitability, with a 66.41% increase in profit. The company's net worth Soared by an impressive increase of 53.02%.

Erotas Pharmaceuticals revenue growth over time
Erotas Pharmaceuticals profit and loss trends over time
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023)YOY Growth
(FY 2022)(FY 2021)(FY 2020)(FY 2019)
Total Revenue
-26.34%
Revenue from Operations
-26.34%
Total Assets
139.73%
Profit or Loss
66.41%
Net Worth
53.02%
EBITDA
45.41%

What is the Ownership and Shareholding Structure of Erotas Pharmaceuticals?

Unlock access to Erotas Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Indicator graph

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)

There are no open charges registered against the company as per our records.

How Many Employees Work at Erotas Pharmaceuticals?

Erotas Pharmaceuticals has a workforce of 0 employees as of Mar 30, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee growth trends for Erotas Pharmaceuticals Private Limited

Deals i

Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Erotas Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Erotas Pharmaceuticals's trajectory.

Rating

Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Latest Updates, News, and FAQs on Erotas Pharmaceuticals

Recent Activity within the Organization

  • Annual General Meeting

    Progress on Erotas Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.

  • Balance Sheet

    Progress on Erotas Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Hyderabad. was documented.

  • Director Appointment

    The activity Pavani Kathi was appointed as a Director was appointed as a Director on 13 Mar 2020 & has been associated with this company since 5 years 8 months . was completed.

  • Director Appointment

    Progress on Ramesh Gamini was appointed as a Director was appointed as a Director on 13 Mar 2020 & has been associated with this company since 5 years 8 months . was documented.

  • Company Incorporation

    Progress on Erotas Pharmaceuticals Private Limited was registered on 13 Mar 2020 with Roc Hyderabad & aged 5 years 8 months as per MCA records. was documented.

Frequently Asked Questions

  • What is the CIN of Erotas Pharmaceuticals Private Limited?

    The CIN of Erotas Pharmaceuticals Private Limited is U24230TG2020PTC139783.

  • Where is Erotas Pharmaceuticals Private Limited headquartered?

    Erotas Pharmaceuticals Private Limited is headquartered at H. No. 5-3-74, Kukatpally,, Hyderabad, Telangana, 500072.

  • When was Erotas Pharmaceuticals Private Limited incorporated?

    Erotas Pharmaceuticals Private Limited was incorporated on 13 March 2020.

  • Who are the current directors of Erotas Pharmaceuticals Private Limited?

    The current directors of Erotas Pharmaceuticals Private Limited are

  • What is the primary industry of Erotas Pharmaceuticals Private Limited?

    The primary industry of Erotas Pharmaceuticals Private Limited is Trade.

  • Is Erotas Pharmaceuticals Private Limited a listed company?

    Erotas Pharmaceuticals Private Limited is unlisted.

  • What is the capital structure of Erotas Pharmaceuticals Private Limited?

    The authorized capital of Erotas Pharmaceuticals Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.

Unlock Business Insights – Explore Instantly!

Search company & director profiles for free and gain access to critical business data.

  • 3.1M+ Companies
  • 15M+ Legal Cases
  • 525K+ Credit Ratings
  • 5.8M+ Directors & KMP
  • 750K+ Regulatory Alerts
  • 1.1M+ Companies' Financial Records
Start Free Trial